Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    9704373 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Botulinum Toxin Type A (Botox) for the Treatment of Cervical Dystonia and Upper Thoracic Muscular Pain
Conditions: Refractory Cervicothoracic Myofascial Pain Syndrome (CMPS);   Cervical Dystonia
Intervention: Drug: Botulinum Toxin Type A

Indicates status has not been verified in more than two years